Corcept Therapeutics Inc (CORT)
50.07
+2.45
(+5.14%)
USD |
NASDAQ |
Nov 04, 16:00
50.07
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 5.246B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 5.246B |
| November 01, 2024 | 4.989B |
| October 31, 2024 | 5.131B |
| October 30, 2024 | 4.913B |
| October 29, 2024 | 5.051B |
| October 28, 2024 | 5.065B |
| October 25, 2024 | 4.954B |
| October 24, 2024 | 4.950B |
| October 23, 2024 | 5.035B |
| October 22, 2024 | 5.122B |
| October 21, 2024 | 5.142B |
| October 18, 2024 | 5.209B |
| October 17, 2024 | 4.939B |
| October 16, 2024 | 4.949B |
| October 15, 2024 | 4.904B |
| October 14, 2024 | 4.743B |
| October 11, 2024 | 4.757B |
| October 10, 2024 | 4.738B |
| October 09, 2024 | 4.810B |
| October 08, 2024 | 4.793B |
| October 07, 2024 | 4.676B |
| October 04, 2024 | 4.757B |
| October 03, 2024 | 4.716B |
| October 02, 2024 | 4.802B |
| October 01, 2024 | 4.895B |
| Date | Value |
|---|---|
| September 30, 2024 | 4.846B |
| September 27, 2024 | 4.590B |
| September 26, 2024 | 4.522B |
| September 25, 2024 | 4.445B |
| September 24, 2024 | 4.598B |
| September 23, 2024 | 4.488B |
| September 20, 2024 | 4.415B |
| September 19, 2024 | 4.276B |
| September 18, 2024 | 4.417B |
| September 17, 2024 | 4.149B |
| September 16, 2024 | 4.020B |
| September 13, 2024 | 3.982B |
| September 12, 2024 | 3.731B |
| September 11, 2024 | 3.715B |
| September 10, 2024 | 3.660B |
| September 09, 2024 | 3.626B |
| September 06, 2024 | 3.592B |
| September 05, 2024 | 3.563B |
| September 04, 2024 | 3.618B |
| September 03, 2024 | 3.580B |
| August 30, 2024 | 3.689B |
| August 29, 2024 | 3.672B |
| August 28, 2024 | 3.599B |
| August 27, 2024 | 3.622B |
| August 26, 2024 | 3.657B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.159B
Minimum
Mar 16 2020
5.246B
Maximum
Nov 04 2024
2.518B
Average
2.473B
Median
Market Cap Benchmarks
| ADMA Biologics Inc | 4.459B |
| Akebia Therapeutics Inc | 387.98M |
| Bioventus Inc | 893.50M |
| Alnylam Pharmaceuticals Inc | 34.82B |
| Catalyst Pharmaceuticals Inc | 2.580B |
Market Cap Related Metrics
| PE Ratio | 39.74 |
| PS Ratio | 8.876 |
| PEG Ratio | 0.7153 |
| Price to Book Value | 8.212 |
| Price to Free Cash Flow | 39.12 |
| Price | 50.07 |
| Earnings Yield | 2.52% |
| PEGY Ratio | 0.7153 |
| Operating PE Ratio | 38.92 |
| Normalized PE Ratio | 39.74 |